In this study, FGF2 mRNA was downregulated in DCIS and invasive breast cancer tumors compared with normal breast tissues but upregulated in blood samples from DCIS and invasive breast cancer patients versus healthy individuals. Here, FGF2 is linked to ductal breast carcinoma in situ.